Faeth Therapeutics (FTH) vs Sagimet Biosciences Series A (SGMT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Faeth Therapeutics (FTH) has outperformed Sagimet Biosciences Series A (SGMT) over the past year, gaining 121.4% versus a gain of 21.0%. Faeth Therapeutics is the larger company by market cap ($643.9 million vs $629.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FTH | SGMT |
|---|---|---|
| Share price | $24.92 | $8.88 |
| Market cap | $643.94M | $629.67M |
| 1-day change | -7.33% | +1.37% |
| YTD return | +133.55% | +50.00% |
| 1-year return | +121.39% | +20.98% |
| 5-year return | -83.67% | — |
| EPS (TTM) | $-60.86 | $-1.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.14 | $11.45 |
| 52-week low | $7.45 | $4.50 |
| Distance from 52-week high | -40.87% | -22.44% |
| Average volume | 348.41K | 1.24M |
| Shares outstanding | 25.84M | 70.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FTH has outperformed SGMT by 100.4 percentage points over the past year.
FTH vs SGMT FAQ
Which is bigger, Faeth Therapeutics or Sagimet Biosciences Series A?
Faeth Therapeutics (FTH) is larger, with a market capitalization of $643.94M compared with $629.67M for Sagimet Biosciences Series A (SGMT).
Which stock has performed better over the past year, FTH or SGMT?
FTH returned +121.39% over the past 12 months, compared with +20.98% for SGMT (price return, excluding dividends). Past performance does not predict future results.
Are Faeth Therapeutics and Sagimet Biosciences Series A in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.